| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in CAI over the last quarter tilts toward buying: insiders added a net 68,000 shares worth roughly $990K.
Classified under Biotechnology (Health Care sector), CAI's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.57M | $59.57M | - | |
| Dir | 704.6K | $16.30M | - | |
| Pres | 530.1K | $12.27M | - | |
| Dir | 309.0K | $7.15M | - | |
| Other | 230.3K | $5.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Halbert Jon | Director | Buy | 68,000 | $14.56 | $990,080.00 | +10.7% | - | - | |
| Dec 11, 2025 | Power Luke Thomas | See Remarks | Sale+OE | 62,250 | $26.58 | $1,654,461.30 | -23.7% | -29.8% | - | |
| Nov 7, 2025 | Denton John Russel | See Remarks | Buy | 4,184 | $24.09 | $100,792.56 | +83.7% | -17.0% | - | |
| Nov 7, 2025 | Spetzler David Baxley | President | Buy | 400 | $23.85 | $9,540.00 | - | -17.0% | - | |
| Jun 20, 2025 | Brille Brian J | See Remarks | Buy | 30,000 | $21.00 | $630,000.00 | +22.7% | +22.7% | -36.5% | |
| Jun 20, 2025 | Denton John Russel | See Remarks | Buy | 7,500 | $21.00 | $157,500.00 | +6.5% | +22.7% | -36.5% |